50 employees
The Onkaido Therapeutics team is exploring how messenger RNA therapeutics™ can deliver novel oncology drugs to help patients.
2013
$20M
from 1 investors over 1 rounds
Onkaido Therapeutics raised $20M on January 14, 2014
Investors: Moderna